Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.* 1349 (1) 2021 (2) A 5 43 44 45 46 70 339 * ........................................................... 1 ...................................................... 5 .............................................. 44 ................................................ 46 ........................ I-1 ............... II-1 ................................................ III-1 –i– A 0.1 A A H H A H H 01349 A 688505 –1– 3,284 86.42% H 0.1 –2– 571 6 516 13.58% A –3– 0.1 H A 3,800 A % * –4– Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.* 1349 308 201210 8 19 (1) 2021 (2) A A (i) (ii) (iii) –5– A A I. II. A III. 3,800 104,300 3.64% 3,284 3.15% 86.42% 516 0.49% 13.58% 20.00% 1.00% –6– IV. A. 1. 4 2. B. 266 628 42.36% –7– C. 1. 2. 3. 4. 5. 6. –8– D. 100 2.63% 0.10% 120 3.16% 0.12% 120 3.16% 0.12% 110 2.89% 0.11% 120 3.16% 0.12% 120 3.16% 0.12% 110 2.89% 0.11% 100 2.63% 0.10% 70 1.84% 0.07% 30 0.79% 0.03% 40 1.05% 0.04% 1,040 27.37% 1.00% 255 * 2,244 59.05% 2.15% 3,284 86.42% 3.15% 516 13.58% 0.49% 3,800 100.00% 3.64% * 255 –9– 20.00% V. A. A 8.95 A A 8.95 B. 1. 8.95 A 2021 4 6 H 4.390 203.87% A 14.55 38.49% 2021 4 6 20 H 4.397 203.55% A 14.81 20 39.57% – 10 – 2021 4 6 60 H 4.544 196.96% A 16.19 60 44.72% 2021 4 6 120 H 4.255 210.34% A 18.60 60 51.88% 2. a) 50% b) 20 60 120 50% – 11 – 8.95 A VI. A. B. – 12 – C. 30% 30% 40% – 13 – 50% 50% D. 1. 25% 2. – 14 – 3. VII. A. 1. a. b. c. d. e. – 15 – 2. a. b. c. d. e. f. B. 1. a. b. c. d. e. – 16 – 2. a. b. c. d. e. f. 3. – 17 – A B C 100% 80% 60% 1 2021 1 2021 1 2021 10.4 10 10 2 2021 2 2021 2 2021 4 4 3 1 2021-2022 1 2021-2022 1 2021-2022 23.9 22.5 22 2 2021-2022 2 2021-2022 2 2021-2022 9 8 7 – 18 – A B C 100% 80% 60% 1 2021-2023 1 2021-2023 1 2021-2023 41.5 38.1 36.4 2 2021-2023 2 2021-2023 2 2021-2023 14 12 11 – 19 – A B C 100% 80% 60% 1 2021-2022 1 2021-2022 1 2021-2022 23.9 22.5 22 2 2021-2022 2 2021-2022 2 2021-2022 9 8 7 1 2021-2023 1 2021-2023 1 2021-2023 41.5 38.1 36.4 2 2021-2023 2 2021-2023 2 2021-2023 14 12 11 – 20 – 4. 100% 80% 60% 0 C 5. – 21 – VIII. A. 1. 2. 3. 4. – 22 – 5. 6. 7. 8. 9. 10. B. 1. – 23 – 2. 3. 4. 5. – 24 – 6. 7. C. 1. 2. 3. – 25 – IX. A. 1. Q Q0 (1 n) Q0 n Q 2. Q Q0 P1 (1 n) (P1 P2 n) Q0 P1 P2 n Q 3. Q Q0 n Q0 n 1 n Q 4. – 26 – B. 1. P P0 (1 n) P0 n P 2. P P0 (P1 P2 n) [P1 (1 n)] P0 P1 P2 n P 3. P P0 n P0 n P 4. P P0-V P0 V P P 0.1 5. – 27 – C. X. A. 1. 2. 3. 4. 5. – 28 – 6. 7. B. 1. 2. 3. 4. 5. 6. 7. – 29 – 8. 9. C. XI. A. – 30 – B. C. 1. a. b. c. d. e. 2. – 31 – 3. 4. D. 1. a. b. c. – 32 – 2. a. b. 3. 4. a. b. 5. a. – 33 – b. 6. 7. a. b. c. d. e. f. 8. – 34 – XII. A. 11 22 = B. 3,800 3,284 A 18,751.64 2021 2022 2023 2024 18,751.64 5,469.23 8,125.71 3,906.59 1,250.11 – 35 – A 3,800 (i) 3,284 266 3.15% (ii) 516 0.49% 460 4 2,824 262 IV. D. A 34,010 3,800 A 8.95 V. A A A 0.10 380 12 – 36 – 97,432.39 1. A 2. 3. 1. (1) (2) (3) (4) – 37 – (5) (6) (7) (8) (9) (10) (11) (12) 2. – 38 – 3. 4. – 39 – H 1349 A 688505 17 14A 14A – 40 – H A 339 H (http://www.hkexnews.hk) (www.fd-zj.com) www.hkex.com.hk H 24 H 183 17M H A H H H H H H – 41 – H H H H H 183 17 1712-1716 (1) 57,886,430 A 5.55% 11 13 2 4 (2) 22,312,860 A 2.14% 11 13 2 4 (3) 19,260,710 A 1.85% 11 13 2 4 (i) (ii) – 42 – – 43 – Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.* 1349 A – 44 – – 45 – A A 38,000,000 3.64%, 32,840,000 5,160,000 4,600,000 4 – 46 – 14A 14A 13.84 – 47 – 1. – 48 – A 833.8 1,029.3 741.8 (139.3) (127.8) (114.3) (50.8) (54.9) (83.6) (426.9) (530.6) (399.6) 173.0 247.5 93.0 164.7 227.4 112.1 – 49 – 2. 4 4,600,000 1,000,000 2.63% 0.10% 1,200,000 3.16% 0.12% 1,200,000 3.16% 0.12% 1,200,000 3.16% 0.12% 4,600,000 12.11% 0.46% A 8.95 A (i) – 50 – H 4.390 203.87% A 14.55 38.49% (ii) 20 H 4.397 203.55% A 14.81 39.57% (iii) 60 H 4.544 196.96% A 16.19 44.72% (iv) 120 H 4.255 210.34% A 18.60 51.88% 48 – 51 – 30% 30% 40% 50% 50% – 52 – (i) (ii) 3. 4 600226 – 53 – 20 – 54 – 4. (i) (ii) 5. A (iii) – 55 – 5. 5.1 A A (a) (b) A A (i) A (ii) A – 56 – A A A 20 60 120 2021 3 31 25.00 20.43 36 65.35% 65.58% 67.17% 61.09% 50%: 12 24 0.91% (688321.SH) 50%: 24 36 2021 3 31 10.00 14.41 48 51.47% 48.71% 43.65% 36.39% 30%: 12 24 2.00% (688556.SH) 30%: 24 36 40%: 36 48 2021 3 31 80.00 47.20 36 45.70% 48.94% 40.94% 48.43% 50%: 12 24 1.25% (688598.SH) 50%: 24 36 2021 3 27 17.50 17.50 60 80.94% 75.46% 83.77% 84.92% 40%: 12 24 4.09% 18.50 (688007.SH) 21.00 30%: 24 36 30%: 36 48 2021 3 27 30.00 16.49 96 50.81% 41.91% 46.38% 46.88% 30%: 12 24 1.00% (688026.SH) 30%: 24 36 40%: 36 48 2021 3 26 15.65 21.59 60 64.49% 65.09% 64.06% 55.31% 30%:12 24 3.53% (688078.SH) 30%:24 36 40%: 36 48 2021 3 26 42.76 15.53 48 50.00% 54.72% 56.23% 57.84% 50%:12 24 0.63% (688139.SH) 30%: 24 36 20%: 36 48 – 57 – A A A 20 60 120 2021 3 25 22.79 20.35 48 97.01% 98.19% 92.21% 74.52% 40%:12 24 6.99% (688159.SH) 30%: 24 36 30%: 36 48 2021 3 16 9.00 14.34 60 55.78% 54.52% 52.60% 43.40% 30%: 12 24 3.26% (688096.SH) 30%: 24 36 40%: 36 48 2021 3 15 25.01 62.57 60 50.01% 50.85% 47.68% 39.04% 20%: 12 24 1.32% (688378. 40%: 24 36 SH) 40%: 36 48 2021 3 4 35.83 33.23 72 81.01% 82.90% 83.19% 70.41% 50%: 24 36 4.91% (688158.SH) 25%: 36 48 25%: 48 60 2021 3 2 21.00 26.90 60 50.00% 50.00% 50.00% 50.00% 30%: 12 24 4.87% (688118.SH) 30%: 24 36 40%: 36 48 96 97.01% 98.19% 92.21% 84.92% 6.99% 36 45.70% 41.91% 40.94% 36.39% 0.63% 57 61.88% 61.41% 60.66% 55.69% 2.90% 60 53.63% 54.62% 54.42% 52.66% 2.63% 2021 4 6 48 61.51% 60.43% 55.28% 48.12% 30%: 12 24 3.64% 30%: 24 36 40%: 36 48 A – 58 – 48 (a) 41.5 14 (b) 14 (a) 8.338 10.3 2.356 (b) 12 4 2 (c) 3 (a) (b) – 59 – A 8.95 (a) A A 14.55 61.51% (b) 20 A A 14.81 60.43% (c) 60 A A 16.19 55.28% (d) 120 A A 18.60 48.12% 10 10.6 (a) 50% (b) 20 60 120 50% (a) A 45.70% 97.01% 61.88% 53.63% – 60 – (b) 20 A 41.91% 98.19% 61.41% 54.62% (c) 60 A 40.94% 92.21% 60.66% 54.42% (d) 120 A 36.39% 84.92% 55.69% 52.66% (e) A (a) (b) (c) (d) H 20 60 120 H (e) A – 61 – 12 48 30% 30% 40% A 12 24 36 48 60 20% – 62 – 1% 38,000,000 A 3.64% (a) (b) (i) (c) (d) (e) 0.12% 5.2 (a) (b) (c) – 63 – 5.2 S&P Capital IQ (i) (ii) (iii) – 64 – 1 656 9,560,000 26,312,000 1061 580,124 2,372,747 2 1358 1,039,000 1530 1,072,000 3,347,000 1801 8,926,000 75,664,000 1877 3,434,000 7,472,000 1952 4,618,000 5,980,000 2142 2,298,348 4,072,856 3 2181 1,432,000 5,949,000 2269 5,622,000 25,196,000 2696 3,939,000 6600 14,527,000 6978 664,000 904,000 6996 1,133,000 3,573,000 6998 15,923,000 8049 218,000 515,000 9688 9926 1,792,000 2,321,000 – 65 – 1 9939 2,278,000 9966 7,203,000 48,152,000 9995 562,000 744,000 1349 2,428,000 3,276,000 4 1. 2. 1 1.1865 3. 1 6.5480 4. 20 7,570 21 9 9 20 500 – 66 – 5.3 (a) (b) (c) A (d) (e) A 20 60 120 A (f) H 20 60 120 H (g) (h) – 67 – 6. (i) XII. 32,840,000 A 18,752 A 38,000,000 (a) A 14.66 (b) A 8.95 38,000,000 21,698 12,980 15.6% (a) 41.5 (b) 12,980 (c) 60,637 12,980 – 68 – 14.6% 15.6% (a) 4 (b) A A (i) 13.969 (a) A 8.95 (b) 38,000,000 3.401 – 69 – 6 6 – 70 – 2021 2021 2021 4 A A 3,800 104,300 3.64% 3,284 3.15% – I-1 – 2021 86.42% 516 0.49% 13.58% 20.00% 1.00% 266 12 8.95 48 – I-2 – 2021 12 30% 30% 40% 12 50% 50% A B C 100% 80% 60% 1 2021 1 2021 1 2021 10.4 10 10 2 2021 2 2021 2 2021 4 4 3 – I-3 – 2021 A B C 100% 80% 60% 1 2021- 1 2021- 1 2021- 2022 2022 2022 23.9 22.5 22 2 2021- 2 2021- 2 2021- 2022 2022 2022 9 8 7 1 2021- 1 2021- 1 2021- 2023 2023 2023 41.5 38.1 36.4 2 2021- 2 2021- 2 2021- 2023 2023 2023 14 12 11 – I-4 – 2021 A B C 100% 80% 60% 1 2021- 1 2021- 1 2021- 2022 2022 2022 23.9 22.5 22 2 2021- 2 2021- 2 2021- 2022 2022 2022 9 8 7 1 2021- 1 2021- 1 2021- 2023 2023 2023 41.5 38.1 36.4 2 2021- 2 2021- 2 2021- 2023 2023 2023 14 12 11 – I-5 – 2021 36 12 12 12 – I-6 – 2021 60 60 60 – I-7 – 2021 ........................................................... I-1 ........................................................ I-1 .................................................... I-9 ......................................... I-11 ..................................... I-12 ................................. I-13 ............................... I-16 .......................... I-17 .......................... I-19 ............................ I-22 ............................... I-24 ............................... I-31 ................................... I-34 ............... I-36 ............................ I-40 ................ I-43 .................................................. I-47 – I-8 – 2021 2021 – I-9 – 2021 4 2021 – I-10 – 2021 – I-11 – 2021 – I-12 – 2021 266 628 42.36% 1 2 3 5% – I-13 – 2021 12 12 12 12 12 10 – I-14 – 2021 5 – I-15 – 2021 A 3,800 104,300 3.64% 3,284 3.15% 86.42% 516 0.49% 13.58% 20.00% 1.00% – I-16 – 2021 100 2.63% 0.10% 120 3.16% 0.12% 120 3.16% 0.12% 110 2.89% 0.11% 120 3.16% 0.12% 120 3.16% 0.12% 110 2.89% 0.11% 100 2.63% 0.10% 70 1.84% 0.07% 30 0.79% 0.03% 40 1.05% 0.04% 1,040 27.37% 1.00% 255 2,244 59.05% 2.15% 3,284 86.42% 3.15% 516 13.58% 0.49% 3,800 100.00% 3.64% – I-17 – 2021 1 1.00% 20.00% 20.00% 2 3 12 – I-18 – 2021 48 60 60 60 12 60 30 10 – I-19 – 2021 2 12 30% 24 24 30% 36 36 40% 48 12 50% 24 24 50% 36 – I-20 – 2021 25% 6 6 – I-21 – 2021 8.95 8.95 8.95 8.95 1 14.55 1 61.53% 20 14.81 20 60.45% 60 16.19 60 55.27% 120 18.60 120 48.13% – I-22 – 2021 8.95 (www.sse.com.cn) 2021 10.6 – I-23 – 2021 1 2 3 36 4 5 1 12 2 12 3 12 4 5 6 – I-24 – 2021 1 2 3 36 4 5 1 12 2 12 3 12 4 5 6 – I-25 – 2021 12 2021 2023 A B C 100% 80% 60% 1 2021 1 2021 1 2021 10.4 10 10 2 2021 2 2021 2 2021 4 4 3 – I-26 – 2021 A B C 100% 80% 60% 1 2021- 1 2021- 1 2021- 2022 2022 2022 23.9 22.5 22 2 2021- 2 2021- 2 2021- 2022 2022 2022 9 8 7 1 2021- 1 2021- 1 2021- 2023 2023 2023 41.5 38.1 36.4 2 2021- 2 2021- 2 2021- 2023 2023 2023 14 12 11 – I-27 – 2021 A B C 100% 80% 60% 1 2021- 1 2021- 1 2021- 2022 2022 2022 23.9 22.5 22 2 2021- 2 2021- 2 2021- 2022 2022 2022 9 8 7 1 2021- 1 2021- 1 2021- 2023 2023 2023 41.5 38.1 36.4 2 2021- 2 2021- 2 2021- 2023 2023 2023 14 12 11 – I-28 – 2021 C 100% 80% 60% 0 C = 3 10 – I-29 – 2021 – I-30 – 2021 Q Q0 (1 n) Q0 n Q Q Q0 P1 (1 n)/(P1 P2 n) Q0 P1 P2 n Q Q Q0 n Q0 n 1 n Q – I-31 – 2021 P P0 (1 n) P0 n P P P0 (P1 P2 n)/[P1 (1 n)] P0 P1 P2 n P P P0 n P0 n P P P0–V P0 V P P 0.1 – I-32 – 2021 – I-33 – 2021 11 22 11 22 = 3,800 3,284 18,751.64 2021 6 2021 2024 2021 2022 2023 2024 18,751.64 5,469.23 8,125.71 3,906.59 1,250.11 – I-34 – 2021 1 2 3 – I-35 – 2021 2 6 10 5 – I-36 – 2021 60 60 – I-37 – 2021 60 60 3 12 12 – I-38 – 2021 1 2 1 2 – I-39 – 2021 – I-40 – 2021 – I-41 – 2021 – I-42 – 2021 1 2 3 36 4 5 5 5 – I-43 – 2021 1 2 3 1 – I-44 – 2021 2 1 2 1 2 – I-45 – 2021 1 12 2 12 3 12 4 5 6 – I-46 – 2021 – I-47 – 2021 2021 2021 – II-1 – – II-2 – 2021 2023 A B C 100% 80% 60% 1 2021 1 2021 1 2021 10.4 10 10 2 2021 2 2021 2 2021 4 4 3 – II-3 – A B C 100% 80% 60% 1 2021- 1 2021- 1 2021- 2022 2022 2022 23.9 22.5 22 2 2021- 2 2021- 2 2021- 2022 2022 2022 9 8 7 1 2021- 1 2021- 1 2021- 2023 2023 2023 41.5 38.1 36.4 2 2021- 2 2021- 2 2021- 2023 2023 2023 14 12 11 – II-4 – A B C 100% 80% 60% 1 2021- 1 2021- 1 2021- 2022 2022 2022 23.9 22.5 22 2 2021- 2 2021- 2 2021- 2022 2022 2022 9 8 7 1 2021- 1 2021- 1 2021- 2023 2023 2023 41.5 38.1 36.4 2 2021- 2 2021- 2 2021- 2023 2023 2023 14 12 11 – II-5 – 100% 80% 60% 0 C = 2021 2023 – II-6 – 1 5 2 10 3 1 2 3 10 – II-7 – – II-8 – 1. 2. XV 7 8 352 A 5,888.06(L) 8.38% 5.65% A 2,310.89(L) 3.29% 2.22% A 2,005.68(L) 2.85% 1.92% A 140.87(L) 0.20% 0.14% A 109.84(L) 0.16% 0.11% 1. L 2. A – III-1 – 99.42 79.61 79.61 23.87 29.84 A XV 352 XV 2 3 336 A 139,578,560 (L) 19.85% 20.15% H 70,564,000 (L) 20.75% A 139,578,560 (L) 19.85% 20.15% H 70,564,000 (L) 20.75% A 156,892,912 (L) 22.32% 15.04% A 80,000,000 (L) 11.38% 7.67% Investco HongKong H 30,835,000 (L) 9.07% 2.96% Limited L XV 2 3 336 – III-2 – 3. 4. (a) (b) 5. 6. 7. – III-3 – 8. 6 (a) (b) 9. (a) 308 201210 (b) 8 19 (c) H 183 17M (d) – III-4 – (e) (f) 10. 14 8 19 (a) 44 45 (b) 46 70 (c) (d) (e) – III-5 –